(Q43069832)

English

Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction

scientific article published on 5 May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Stanley C Jordan

6

object named as

Stanley C Jordan

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Kavita G Sharma

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Raju Radha

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Andy Pao

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Nurmamet Amet

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Lara Baden

5

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Mieko Toyoda

7

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

5 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

117-120

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Mycophenolate mofetil and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Use of mycophenolate mofetil in autoimmune and renal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Anti-inflammatory actions of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Common variable immune deficiency and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Modulation of the cellular immune system by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Advances in the understanding of the mechanism of action of IVIg

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Protective mechanisms of IVIG.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Intravenous immunoglobulin a natural regulator of immunity and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Rituximab and intravenous immune globulin for desensitization during renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Advances in diagnosing and managing antibody-mediated rejection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

The effect of renal insufficiency on mycophenolic acid protein binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Positive effect on T-cell regulatory apoptosis by mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Augmentation of T-cell apoptosis by immunosuppressive agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Apoptosis and transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Cytokine-induced survival of activated T cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2010.04.009

7 January 2021

Identifiers

10.1016/J.TRIM.2010.04.009

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43069832&oldid=2070339405"